Digestion of Human Milk Oligosaccharides by Bifidobacterium breve in the Premature Infant

Journal of Pediatric Gastroenterology and Nutrition

Volumn 65, Issue 4, 2017, Pages 449-455

  Underwood, Mark A ^a   Davis, Jasmine C C ^b   Kalanetra, Karen M ^b   Gehlot, Sanjay ^c   Patole, Sanjay ^c   Tancredi, Daniel J ^a   Mills, David A ^b   Lebrilla, Carlito B ^b   Simmer, Karen ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

glycan; intestinal microbiota; necrotizing enterocolitis; prebiotic; probiotic

Indexed keywords

BACTERIAL RNA; HUMAN MILK OLIGOSACCHARIDE; OLIGOSACCHARIDE; PROBIOTIC AGENT; RNA 16S; UNCLASSIFIED DRUG;

ARTICLE; AUSTRALIA; BACTERIAL COUNT; BIFIDOBACTERIUM; BIFIDOBACTERIUM BREVE; BREAST MILK; CARBOHYDRATE ABSORPTION; CARBOHYDRATE ANALYSIS; CARBOHYDRATE INTAKE; CLINICAL ARTICLE; COHORT ANALYSIS; DIGESTION; ENTEROBACTERIACEAE; FECES LEVEL; FECES MICROFLORA; FEMALE; FUCOSYLATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; MILK LEVEL; NANOANALYSIS; NEWBORN; NEWBORN INTENSIVE CARE; NEXT GENERATION SEQUENCING; NONHUMAN; PREMATURITY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TIME OF FLIGHT MASS SPECTROMETRY; URINE LEVEL; CHEMISTRY; HIGH THROUGHPUT SEQUENCING; INFANT; INTESTINE FLORA; MASS SPECTROMETRY; PHYSIOLOGY;

AUSTRALIA; BIFIDOBACTERIUM BREVE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIGESTION; FEMALE; GASTROINTESTINAL MICROBIOME; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; MALE; MASS SPECTROMETRY; MILK, HUMAN; OLIGOSACCHARIDES; PROBIOTICS;

EID: 85029766648     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/MPG.0000000000001590     Document Type: Article

References (50)

1. Carlisle EM, Poroyko V, Caplan MS, et al. Gram negative bacteria are associated with the early stages of necrotizing enterocolitis. PloS One 2011;6:e18084.
2. Cilieborg MS, Boye M, Molbak L, et al. Preterm birth and necrotizing enterocolitis alter gut colonization in pigs. Pediatr Res 2011;69:10-6.
3. Underwood MA, Arriola J, Gerber CW, et al. Bifidobacterium longum subsp. infantis in experimental necrotizing enterocolitis: alterations in inflammation, innate immune response, and the microbiota. Pediatr Res 2014;76:326-33.
4. Wang Y, Hoenig JD, Malin KJ, et al. 16S rRNA gene-based analysis of fecal microbiota from preterm infants with and without necrotizing enterocolitis. ISME J 2009;3:944-54.
5. Mai V, Young CM, Ukhanova M, et al. Fecal microbiota in premature infants prior to necrotizing enterocolitis. PloS One 2011;6:e20647.
6. Claud EC, Keegan KP, Brulc JM, et al. Bacterial community structure and functional contributions to emergence of health or necrotizing enterocolitis in preterm infants. Microbiome 2013;1:20.
7. Warner BB, Deych E, Zhou Y, et al. Gut bacteria dysbiosis and necrotising enterocolitis in very low birthweight infants: a prospective case-control study. Lancet 2016;387:1928-36.
8. Alfaleh K, Anabrees J. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev 2014;4: CD005496.
9. Patel RM, Denning PW. Therapeutic use of prebiotics, probiotics, and postbiotics to prevent necrotizing enterocolitis: what is the current evidence? Clin Perinatol 2013;40:11-25.
10. Charbonneau MR, O'Donnell D, Blanton LV, et al. Sialylated milk oligosaccharides promote microbiota-dependent growth in models of infant undernutrition. Cell 2016;164:859-71.
11. Garrido D, Dallas DC, Mills DA. Consumption of human milk glycoconjugates by infant-associated bifidobacteria: mechanisms and implications. Microbiology (Reading, England) 2013;159:649-64.
12. Asakuma S, Hatakeyama E, Urashima T, et al. Physiology of consumption of human milk oligosaccharides by infant gut-associated bifidobacteria. J Biol Chem 2011;286:34583-92.
13. Garrido D, Ruiz-Moyano S, Lemay DG, et al. Comparative transcriptomics reveals key differences in the response to milk oligosaccharides of infant gut-associated bifidobacteria. Sci Rep 2015;5:13517.
14. Ruiz-Moyano S, Totten SM, GarridoDA, et al. Variation in consumption of human milk oligosaccharides by infant gut-associated strains of Bifidobacterium breve. Appl Environ Microbiol 2013;79:6040-9.
15. Wang M, Li M,Wu S, et al. Fecal microbiota composition of breast-fed infants is correlated with human milk oligosaccharides consumed. J Pediatr Gastroenterol Nutr 2015;60:825-33.
16. McGovern DP, Jones MR, Taylor KD, et al. Fucosyltransferase 2 (FUT2) non-secretor status is associated with Crohn's disease. Hum Mol Genet 2010;19:3468-76.
17. Marionneau S, Ruvoen N, Le Moullac-Vaidye B, et al. Norwalk virus binds to histo-blood group antigens present on gastroduodenal epithelial cells of secretor individuals. Gastroenterology 2002;122:1967-77.
18. Morrow AL, Meinzen-Derr J, Huang P, et al. Fucosyltransferase 2 nonsecretor and low secretor status predicts severe outcomes in premature infants. J Pediatr 2011;158:745-51.
19. Demmert M, Schaper A, Pagel J, et al. FUT 2 polymorphism and outcome in very-low-birth-weight infants. Pediatr Res 2015;77:586-90.
20. Lewis ZT, Totten SM, Smilowitz JT, et al. Maternal fucosyltransferase 2 status affects the gut bifidobacterial communities of breastfed infants. Microbiome 2015;3:13.
21. Bokulich NA, Mills DA. Facility-specific "house" microbiome drives microbial landscapes of artisan cheesemaking plants. Appl Environ Microbiol 2013;79:5214-23.
22. Underwood MA, Kalanetra KM, Bokulich NA, et al. A comparison of two probiotic strains of bifidobacteria in premature infants. J Pediatr 2013;163:1585-91 e9.
23. Caporaso JG, Lauber CL, Walters WA, et al. Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample. Proc Natl Acad Sci U S A 2011;108(suppl 1):4516-22.
24. Edgar RC. Search and clustering orders of magnitude faster than BLAST. Bioinformatics 2010;26:2460-1.
25. Wang Q, Garrity GM, Tiedje JM, et al. Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl Environ Microbiol 2007;73:5261-7.
26. DeSantis TZ, Hugenholtz P, Larsen N, et al. Greengenes, a chimerachecked 16S rRNA gene database and workbench compatible with ARB. Appl Environ Microbiol 2006;72:5069-72.
27. Ninonuevo MR, Park Y, Yin H, et al. A strategy for annotating the human milk glycome. J Agric Food Chem 2006;54:7471-80.
28. Wu S, Tao N, German JB, et al. Development of an annotated library of neutral human milk oligosaccharides. J Proteome Res 2010;9:4138-51.
29. De Leoz ML, Wu S, Strum JS, et al. A quantitative and comprehensive method to analyze human milk oligosaccharide structures in the urine and feces of infants. Anal Bioanal Chem 2013;405:4089-105.
30. Totten SM, Wu LD, Parker EA, et al. Rapid-throughput glycomics applied to human milk oligosaccharide profiling for large human studies. Anal Bioanal Chem 2014;406:7925-35.
31. Wu S, Grimm R, German JB, et al. Annotation and structural analysis of sialylated human milk oligosaccharides. J Proteome Res 2011;10: 856-68.
32. Totten SM, Zivkovic AM,Wu S, et al. Comprehensive profiles of human milk oligosaccharides yield highly sensitive and specific markers for determining secretor status in lactating mothers. J Proteome Res 2012;11:6124-33.
33. La Rosa PS,Warner BB, Zhou Y, et al. Patterned progression of bacterial populations in the premature infant gut. Proc Natl Acad Sci U S A 2014;111:12522-7.
34. Arboleya S, Sanchez B, Solis G, et al. Impact of prematurity and perinatal antibiotics on the developing intestinal microbiota: a functional inference study. Int J Mol Sci 2016;17:649.
35. De Leoz ML, Gaerlan SC, Strum JS, et al. Lacto-N-tetraose, fucosylation, and secretor status are highly variable in human milk oligosaccharides from women delivering preterm. J Proteome Res 2012;11:4662-72.
36. Huda MN, Lewis Z, Kalanetra KM, et al. Stool microbiota and vaccine responses of infants. Pediatrics 2014;134:E362-72.
37. Turroni F, Peano C, Pass DA, et al. Diversity of bifidobacteria within the infant gut microbiota. PloS One 2012;7:e36957.
38. Vatanen T, Kostic AD, d'Hennezel E, et al. Variation in microbiome LPS immunogenicity contributes to autoimmunity in humans. Cell 2016;165:842-53.
39. Sugahara H, Odamaki T, Xiao J. Genotypic and phenotypic evaluation revealed the appropriateness of human-residential bifidobacteria for human use. Milk Sci 2015;64:261-9.
40. Odamaki T, Horigome A, Sugahara H, et al. Comparative genomics revealed genetic diversity and species/strain-level differences in carbohydrate metabolism of three probiotic bifidobacterial species. Int J Genom 2015;2015:567809.
41. Vongbhavit K, Underwood MA. Prevention of necrotizing enterocolitis through manipulation of the intestinal microbiota of the premature infant. Clin Ther 2016;38:716-32.
42. Patole S, Keil AD, Chang A, et al. Effect of Bifidobacterium breve M-16 V supplementation on fecal bifidobacteria in preterm neonates - a randomised double blind placebo controlled trial. PloS One 2014;9:e89511.
43. Patole SK, Rao SC, Keil AD, et al. Benefits of Bifidobacterium breve M-16 V supplementation in preterm neonates - a retrospective cohort study. PloS One 2016;11:e0150775.
44. Costeloe K, Hardy P, Juszczak E, et al. Probiotics in Preterm Infants Study Collaborative G. Bifidobacterium breve BBG-001 in very preterm infants: a randomised controlled phase 3 trial. Lancet 2016;387:649-60.
45. Deshpande G, Rao S, Athalye-Jape G, et al. Probiotics in very preterm infants: the PiPS trial. Lancet 2016;388:655.
46. Underwood MA, Gaerlan S, De Leoz ML, et al. Human milk oligosaccharides in premature infants: absorption, excretion, and influence on the intestinal microbiota. Pediatr Res 2015;78:670-7.
47. Cilieborg MS, Bering SB, Ostergaard MV, et al. Minimal short-term effect of dietary 2'-fucosyllactose on bacterial colonisation, intestinal function and necrotising enterocolitis in preterm pigs. Br J Nutr 2016;116:834-41.
48. Autran CA, Schoterman MH, Jantscher-Krenn E, et al. Sialylated galacto-oligosaccharides and 2'-fucosyllactose reduce necrotising enterocolitis in neonatal rats. Br J Nutr 2016;116:294-9.
49. Good M, Sodhi CP, Yamaguchi Y, et al. The human milk oligosaccharide 2'-fucosyllactose attenuates the severity of experimental necrotising enterocolitis by enhancing mesenteric perfusion in the neonatal intestine. Br J Nutr 2016;116:1175-87.
50. Jantscher-Krenn E, Zherebtsov M, Nissan C, et al. The human milk oligosaccharide disialyllacto-N-tetraose prevents necrotising enterocolitis in neonatal rats. Gut 2012;61:1417-25.